
Profitability, historical returns, and peer comparisons.
According to Shattuck Labs, Inc.’s latest financial reports and current stock price. The company's current ROE is -43.57%. This represents a change of 258.20% compared to the average of -12.16% of the last 4 quarters.
The mean historical ROE of Shattuck Labs, Inc. over the last ten years is -20.55%. The current -43.57% ROE has changed 112.00% with respect to the historical average. Over the past ten years (40 quarters), STTK's ROE was at its highest in in the December 2019 quarter at 21.33%. The ROE was at its lowest in in the March 2020 quarter at -45.15%.
Average
-20.55%
Median
-37.21%
Minimum
-94.71%
Maximum
69.42%
Discovering the peaks and valleys of Shattuck Labs, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 249.73%
Maximum Annual ROE = 69.42%
Minimum Annual Increase = -117.02%
Minimum Annual ROE = -94.71%
| Year | ROE | Change |
|---|---|---|
| 2025 | -59.24% | -37.45% |
| 2024 | -94.71% | 56.98% |
| 2023 | -60.33% | 4.24% |
| 2022 | -57.87% | 249.73% |
| 2021 | -16.55% | 40.08% |
| 2020 | -11.81% | -117.02% |
| 2019 | 69.42% | 4.12% |
The current ROE of Shattuck Labs, Inc. (STTK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-71.42%
5-year avg
-57.74%
10-year avg
-20.55%
Shattuck Labs, Inc.’s ROE is greater than Iovance Biotherapeutics, Inc. (-40.51%), less than Puma Biotechnology, Inc. (20.85%), greater than NovaBridge Biosciences (-1.45%), greater than SELLAS Life Sciences Group, Inc. (-35.91%), greater than Faeth Therapeutics, Inc. (-155.46%), greater than Indaptus Therapeutics, Inc. (-302.75%), greater than Crescent Biopharma, Inc. (-97.77%), greater than CEL-SCI Corporation (-202.14%), greater than PDS Biotechnology Corporation (-708.20%), greater than Black Diamond Therapeutics, Inc. (-38.80%),
| Company | ROE | Market cap |
|---|---|---|
| -40.51% | $3.94B | |
| 20.85% | $551.82M | |
| -1.45% | $116.42M | |
| -35.91% | $1.85B | |
| -155.46% | $515.32M | |
| -302.75% | $373.70M | |
| -97.77% | $513.33M | |
| -202.14% | $24.27M | |
| -708.20% | $72.56M | |
| -38.80% | $108.87M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shattuck Labs, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Shattuck Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Shattuck Labs, Inc.'s ROE?
How is the ROE calculated for Shattuck Labs, Inc. (STTK)?
What is the highest ROE for Shattuck Labs, Inc. (STTK)?
What is the 3-year average ROE for Shattuck Labs, Inc. (STTK)?
What is the 5-year average ROE for Shattuck Labs, Inc. (STTK)?
How does the current ROE for Shattuck Labs, Inc. (STTK) compare to its historical average?